As reported by Alkan et al., AGC1 silencing reduces the proliferation rate of C2C12 cells as well as LLC1 and H1299 (lung), PANC1 and Capan2 (pancreatic), and Hela (cervical) cancer cells, due to impaired aspartate metabolism [85]. The gene discussed is SLC25A12; the disease is cancer.